Xiong, N
- Embora raras, j foram relatados casos de: hiperacidez, reduo do apetite, nuseas, vmitos, priso de ventre ou diarreia e irritao do aparelho digestivo, nervosismo, insnia, taquicardia
The authors hypothesized that these alterations may contribute to catabolism and impaired growth in children suffering from long-standing nephrotic syndrome
Why GLP-1 Therapy May Influence Magnesium Potential pathways: Reduced food volume Reduced whole grain intake Diarrhoea-related loss (in symptomatic individuals) Increased metabolic demand during rapid weight loss Magnesium absorption occurs in the small intestine and is dose-dependent
This, in turn, decreases the risk of heart diseases, increasing the patient's adherence to the treatment
That matters because the question is rarely only whether the scale moved